About 93,858 results

ALLMedicine™ Prostate Cancer Center

Research & Reviews  31,216 results

Contributions of social factors to disparities in prostate cancer risk profiles among B...
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Press DJ, Shariff-Marco S et. al.

Dec 3rd, 2021 - Black men are more likely than Non-Hispanic White (NHW) men to be diagnosed with high-risk prostate cancer (PCa). We examined the extent to which social factors were associated with differences in PCa risk profiles between Black men and NHW men (u...

Instagram and prostate cancer: using validated instruments to assess the quality of inf...
https://doi.org/10.1038/s41391-021-00473-7 10.1007/s00345-018-2254-2 10.1016/j.eururo.2018.10.056 10.1111/bju.15081 10.1080/10810730.2019.1617807 10.1590/S1677-5538.IBJU.2019.05.04 10.1016/j.euf.2019.07.004
Prostate Cancer and Prostatic Diseases; Xu AJ, Myrie A et. al.

Dec 3rd, 2021 - The quality of prostate cancer (PCa) content on Instagram is unknown. We examined 62 still-images and 64 video Instagram posts using #prostatecancer on 5/18/20. Results were assessed with validated tools. Most content focused on raising awareness ...

Prostate cancer risk stratification via non-destructive 3D pathology with deep learning...
Cancer Research; Xie W, Reder NP et. al.

Dec 3rd, 2021 - Prostate cancer treatment planning is largely dependent upon examination of core-needle biopsies. The microscopic architecture of the prostate glands forms the basis for prognostic grading by pathologists. Interpretation of these convoluted 3D gla...

see more →

Guidelines  74 results

The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate...
European Urology Focus; Beyer K, MacLennan SJ et. al.

Oct 5th, 2021 - Patients are the stewards of their own care and hence their voice is important when designing and implementing research. Patients should be involved not only as participants in research that impacts their care, as the recipients of that care and a...

NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
Journal of the National Comprehensive Cancer Network : JN... Schaeffer E, Srinivas S et. al.

Feb 6th, 2021 - The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease. Recommendations for disease monitoring and treatment of r...

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: A...
Journal of Clinical Oncology : Official Journal of the Am... Virgo KS, Rumble RB et. al.

Jan 27th, 2021 - Update all preceding ASCO guidelines on initial hormonal management of noncastrate advanced, recurrent, or metastatic prostate cancer. The Expert Panel based recommendations on a systematic literature review. Recommendations were approved by the E...

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
Practical Radiation Oncology; Zietman AL,

Dec 15th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|radiotherapy,

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, ...
European Urology; Mottet N, van den Bergh RCN et. al.

Nov 12th, 2020 - To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-Internatio...

see more →

Drugs  197 results see all →

Clinicaltrials.gov  1,581 results

Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer

Nov 25th, 2021 - In 2018, 30,000 patients were diagnosed metastatic prostate cancer in the US. Short-course radiation therapy (RT) is a mainstay of treatment for symptomatic metastases, and it stimulates an immune response against the tumor. However, RT also decre...

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Nov 25th, 2021 - PRIMARY OBJECTIVE: I. To evaluate efficacy of erdafitinib in subjects with advanced prostate cancer who have progressed on a second-generation androgen receptor (AR)-targeting agents (SART). SECONDARY OBJECTIVES: I. To evaluate the objective respo...

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Nov 25th, 2021 - Efficacy and safety of Noni extract will be assessed in an estimated sample size of 30 subjects. Efficacy will be measured by the induction of favorable gene expression changes on Oncotype Dx Prostate Cancer Test after 12 months of intervention wi...

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Nov 25th, 2021 - Background: Active Surveillance (AS) is a standard approach in the treatment of low and intermediate risk prostate cancer which employs a strategy of monitoring the clinical progression of prostate cancer. AS utilizes prostate biopsies, prostate s...

Vaccine Response With NT-I7

Nov 25th, 2021 - Background: Interleukin-7 is a homeostatic cytokine with a critical role in lymphoid homeostasis through which it exerts its immune-restorative effects, particularly re-expansion of the na(SqrRoot) ve and memory T-cell subsets. The clinical implic...

see more →

News  4,413 results

Antibody-Drug Conjugates Take Center Stage in NSCLC

Nov 22nd, 2021 - Antibody-drug conjugates (ADCs) targeting TROP2, HER2, and, most recently, B7H3 have taken the field of non–small cell lung cancer (NSCLC) by storm, said Melissa Johnson, MD. She added that the TROP2-directed ADC, datopotamab deruxtecan, has the p...

Prostate cancer: Surgery lowers mortality risk in high-risk group

Nov 15th, 2021 - Key clinical point: Radical prostatectomy vs external beam radiotherapy (EBRT) is associated with significant improvement in cancer-specific mortality in patients with National Comprehensive Cancer Network (NCCN) high-risk and Johns Hopkins Univer.

Increase in PSA testing after 2017 USPSTF recommendations

Nov 15th, 2021 - Key clinical point: Prostrate-specific antigen (PSA) testing increased after the 2017 United States Preventive Services Task Force (USPSTF) draft statement for prostate cancer screening. Major finding: A relative increase of 12.

Prostate cancer: Salvage LDR brachytherapy after EBRT shows good response

Nov 15th, 2021 - Key clinical point: Salvage low-dose-rate (LDR) prostate brachytherapy shows good survival in patients with low-/intermediate-risk prostate cancer who had local failure after external beam radiotherapy (EBRT). Major finding: The median follow-up w.

Institutional Perspectives in Cancer- Precision Medicine: Chaired by Jyoti Patel, MD

Nov 15th, 2021 - Institutional Perspectives in Cancer- Precision Medicine: Chaired by Jyoti Patel, MD The live filming of this virtual event in our IPC series is now on-demand. OncLive is proud to present the State of the Science Summits and a new virtual even...

see more →

Patient Education  62 results see all →